The Cancer Center Flow Cytometry Resource exists to provide state-of-the-art instrumentation and expertise for members'needs. This Resource has existed since 1989 and is a highly utilized core at BCM. The Core has a high pressure, high speed sorting instrument and two analytical instruments. Techniques include flow measures of cell cycle, immunofluoresence, functional measurements, and sorting of cells, including stem cells. Dr. Dorothy Lewis, the Resource Director, has more that 25 years of flow experience and has a highly trained staff to meet users'needs. Dr. Lewis also teaches a flow cytometric applications graduate level course, and has open houses to foster information flow about uses of flow cytometry in cancer research. Cancer Center members currently utilize more than 60% of the Core's billable time, studying a variety of cancer biology questions. In 2004-2005, more than 25 publications resulted from the use of the Core. A charge-back system is in place, along with policies and procedures for fair usage and quality control of the instrumentation. The principal use of the proposed Cancer Center budget for this Resource will be to pay for additional personnel to reduce sorting charges to Cancer Center members by 20-30%. The Resource will thus be armed to provide Cancer Center members even better support in the future.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA125123-03
Application #
7900428
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2009-07-01
Budget End
2010-06-30
Support Year
3
Fiscal Year
2009
Total Cost
$65,029
Indirect Cost
Name
Baylor College of Medicine
Department
Type
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Zhao, Na; Cao, Jin; Xu, Longyong et al. (2018) Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer. J Clin Invest 128:1283-1299
Reznik, Ed; Luna, Augustin; Aksoy, Bülent Arman et al. (2018) A Landscape of Metabolic Variation across Tumor Types. Cell Syst 6:301-313.e3
Blue, R Eric; Koushik, Amrita; Engels, Nichlas M et al. (2018) Modulation of alternative splicing of trafficking genes by genome editing reveals functional consequences in muscle biology. Int J Biochem Cell Biol 105:134-143
Dawson, Emily P; Lanza, Denise G; Webster, Nicholas J et al. (2018) Delayed male germ cell sex-specification permits transition into embryonal carcinoma cells with features of primed pluripotency. Development 145:
Freire, Pablo R; Conneely, Orla M (2018) NR4A1 and NR4A3 restrict HSC proliferation via reciprocal regulation of C/EBP? and inflammatory signaling. Blood 131:1081-1093
Parikh, Neha; Shuck, Ryan L; Gagea, Mihai et al. (2018) Enhanced inflammation and attenuated tumor suppressor pathways are associated with oncogene-induced lung tumors in aged mice. Aging Cell 17:
Brunetti, Lorenzo; Gundry, Michael C; Kitano, Ayumi et al. (2018) Highly Efficient Gene Disruption of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9. J Vis Exp :
Newton, Jared M; Flores-Arredondo, Jose H; Suki, Sarah et al. (2018) Non-Invasive Radiofrequency Field Treatment of 4T1 Breast Tumors Induces T-cell Dependent Inflammatory Response. Sci Rep 8:3474
Bhat, Raksha R; Yadav, Puja; Sahay, Debashish et al. (2018) GPCRs profiling and identification of GPR110 as a potential new target in HER2+ breast cancer. Breast Cancer Res Treat 170:279-292
Lyon, Deborah; Lapteva, Natasha; Gee, Adrian P (2018) Absence of Replication-Competent Retrovirus in Vectors, T Cell Products, and Patient Follow-Up Samples. Mol Ther 26:6-7

Showing the most recent 10 out of 991 publications